Table 1 Clinical features of all the patients
Variables | |
|---|---|
Male, n (%) | 63 (68) |
Age, years; median (IQR) | 29 (25–37) |
Disease duration, years; median (IQR) | 3 (1–6) |
Montreal classification [13] | |
Age at diagnosis (years), n (%) | |
A1 (under 16) | 2 (2.15) |
A2 (17–40) | 74 (79.57) |
A3 (over 40) | 17 (18.28) |
Disease location, n (%) | |
L1 (terminal ileum)/(*L4) | 15 (16.13)/9 (9.68) |
L2 (colon)/(*L4) | 12 (12.90)/2(2.15) |
L3 (ileum plus colon)/(*L4) | 66 (70.97)/37 (39.78) |
Disease behavior, n (%) | |
B1 (nonstricturing, nonpenetrating) | 49 (52.69) |
B2 (stricturing) | 12 (12.90) |
B3 (penetrating) | 32 (34.41) |
Perianal involvement, n (%) | 37 (39.78) |
Surgical history, n (%) | |
History of perianal surgery | 28 (30.11) |
History of partial bowel resection | 3 (3.23) |
Treatment, n (%) | |
No treatment | 15 (16.13) |
Steroids | 10 (10.75) |
Immunomodulator | 31 (33.33) |
Anti-TNF inhibitor | 37 (39.78) |
Abdominal abscess, n (%) | 3 (3.23) |
Intestinal fistula, n (%) | 5 (5.38) |
Colovesical fistula, n (%) | 1 (1.08) |
Ileal bladder fistula, n (%) | 1 (1.08) |